Denali Therapeutics
DNLI
₹1,174
Share price
11.80%
Change (1 day)
-31.56%
Change (1 year)
Categories
Earnings for Denali Therapeutics (DNLI)
Earnings in 2024 (TTM): -₹42.2 Billion
According to Denali Therapeutics 's latest financial reports the company's current earnings are N/A. a decrease over its 2023 earnings that were of -₹16.81 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for Denali Therapeutics from 2017 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | -₹42.88 Billion | 155.15% |
| 2023 | -₹16.81 Billion | -42.27% |
| 2022 | -₹29.11 Billion | 15.21% |
| 2021 | -₹25.27 Billion | -571.56% |
| 2020 | ₹5.35 B | -129.42% |
| 2019 | -₹18.22 Billion | 359.73% |
| 2018 | -₹3.97 Billion | -48.56% |
| 2017 | -₹7.71 Billion |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | -₹10.33 Billion | -75.93% | Jersey |
 | -₹13.38 Billion | -68.81% | 🇺🇸 USA |
 | -₹1.06 Billion | -97.53% | 🇺🇸 USA |
 | -₹6.25 Billion | -85.44% | 🇬🇧 UK |